Clinical & Translational Research Center (CTRC)

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo	Skin and Connective Tissue Diseases, hypopigmentation of the skin, skin disorder, skin pigmentation disorder, vitiligo	Active, not recruiting	Phase 3	2026-09-28		NCT06163326
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata	Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypotrichosis, skin disorder	Recruiting	Phase 3	2026-09-18		NCT06873945

Clinical trials